Vaccine trial

Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1

Laura E. McCoy, Lucy Rutten, Dan Frampton, Ian Anderson, Luke A. Granger, Rachael Bashford-Rogers, Gillian Dekkers, Nika M. Strokappe, Michael S. Seaman, Willie Koh, Vanina Grippo, Alexander Kliche, Theo Verrips, Paul Kellam, Ariberto Fassati, Robin A. Weiss

Citations: 46 • 2014

Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to <scp>HIV</scp>‐1

Peter D. Kwong, Gwo‐Yu Chuang, Brandon J. DeKosky, Tatyana Gindin, Ivelin S. Georgiev, Thomas Lemmin, Chaim A. Schramm, Zizhang Sheng, Cinque Soto, An‐Suei Yang, John R. Mascola, Lawrence Shapiro

Citations: 37 • 2017

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials

Anke Schultz, Stefanie Koch, Martina Fuss, Angela S. Mazzotta, Marcella Sarzotti‐Kelsoe, Daniel A. Ozaki, David C. Montefiori, Hagen von Briesen, Heiko Zimmermann, Andreas Meyerhans

Citations: 20 • 2012

Development of a Stable MGAT1− CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies

Rachel C. Doran, Bin Yu, Meredith Wright, Sara M. O’Rourke, Lu Yin, Jennie M. Richardson, Gabriel Byrne, Kathryn A. Mesa, Phillip W. Berman

Citations: 3 • 2018